| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,397 |
6,018 |
$640K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,987 |
2,679 |
$205K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,077 |
1,056 |
$122K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
443 |
411 |
$37K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
328 |
311 |
$31K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,820 |
2,549 |
$5K |
| 99215 |
Prolong outpt/office vis |
28 |
28 |
$3K |
| 99000 |
|
486 |
454 |
$296.33 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
72 |
51 |
$180.29 |
| 94760 |
|
305 |
257 |
$26.82 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
14 |
12 |
$1.50 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
12 |
12 |
$0.00 |
| 81002 |
|
16 |
14 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
31 |
27 |
$0.00 |